Latest Derivatives News

Page 13 of 44
NexGen Energy Ltd. reported a significant net loss for the nine months ended September 30, 2025, driven by mark-to-market losses on convertible debentures and impairment charges. The company bolstered its liquidity with a $953 million equity raise post-period.
Maxwell Dee
Maxwell Dee
10 Nov 2025
Perpetual Credit Income Trust (PCI) has announced a $267 million entitlement and shortfall offer priced at $1.10 per unit, aiming to bolster its investment capacity in Australian credit markets. The offer presents a 9.1% discount to recent trading prices and is designed to enhance liquidity and scale for existing and new investors.
Victor Sage
Victor Sage
10 Nov 2025
Macquarie Group reported a 3% rise in net profit to A$1.655 billion for the half year ended September 2025, driven by strong growth in asset management and capital divisions. The group also extended its A$2 billion share buyback program and declared a solid interim dividend.
Victor Sage
Victor Sage
7 Nov 2025
Macquarie Group Limited has announced a quarterly distribution of AUD 1.5799 per security on its perpetual capital notes, reflecting a steady income stream with partial franking. The payment is scheduled for December 12, 2025.
Victor Sage
Victor Sage
7 Nov 2025
Macquarie Group Limited announces a quarterly dividend of AUD 1.4003 per security on its CAP NOTE 3-BBSW+2.90% PERP NON-CUM RED T-09-27, with a partly franked distribution and a payment date set for December 18, 2025.
Victor Sage
Victor Sage
7 Nov 2025
Macquarie Group Limited has announced a quarterly distribution of AUD 1.6773 per security for its capital note, payable on December 10, 2025, reflecting a stable income stream for investors.
Victor Sage
Victor Sage
7 Nov 2025
Immuron Limited has secured FDA approval for its IMM-529 Investigational New Drug application, clearing the way for a Phase 2 clinical trial targeting Clostridioides difficile infection. This milestone marks a significant step forward for a novel oral antibody therapy addressing a critical infectious disease with high recurrence rates.
Ada Torres
Ada Torres
5 Nov 2025
Australian Gold and Copper Ltd has completed the acquisition of a key exploration licence in the South Cobar Basin, expanding its footprint to 2,600 km² and setting the stage for accelerated exploration.
Maxwell Dee
Maxwell Dee
5 Nov 2025
McLaren Minerals has identified a promising second shoreline adjacent to its existing McLaren Titanium Project resource, revealing fresh exploration potential within historical data. The company plans further drilling in early 2026 to validate and expand this new target.
Maxwell Dee
Maxwell Dee
4 Nov 2025
Green360 Technologies has independently verified its Eco-Clay product as a high-performance, low-carbon cement substitute made from kaolin waste, poised to disrupt Australia’s $3.5 billion cement market.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Visionflex Group has converted $3.25 million of debt into equity at a 100% premium, emerging debt-free and poised for growth. The company’s Q1 FY26 results show a 34% increase in annual recurring revenue, supported by new product launches targeting the expanding virtual healthcare market.
Victor Sage
Victor Sage
31 Oct 2025
Bio-Gene Technology Limited reports significant progress in Q1 FY26, unveiling new product opportunities and positive efficacy data, alongside securing US Department of Defense grants.
Ada Torres
Ada Torres
31 Oct 2025